These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12962369)

  • 21. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.
    Lena MD; Ramlau R; Hansen O; Lorusso V; Wagner L; Barni S; Cristovao MM; Huber R; Alberola V; Mitrovic M; Colin C; Gasmi J
    Lung Cancer; 2005 Apr; 48(1):129-35. PubMed ID: 15777980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Induction chemotherapy with cisplatin and peplomycin in squamous cell carcinoma of the head and neck].
    Takagi T; Sakai C; Oguro M; Omura K; Shimada H; Takemiya S; Kuwahara T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):543-6. PubMed ID: 2434031
    [No Abstract]   [Full Text] [Related]  

  • 23. Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of the head and neck.
    Faivre S; Marti A; Rixe O; Janot F; Julieron M; Gatineau M; Temam S; Armand JP; Domenge C; Luboinski B; Raymond E
    Head Neck; 2005 Apr; 27(4):311-9. PubMed ID: 15700290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II study of vinorelbine/cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing after at least two chemotherapy regimens.
    Massa E; Dessì M; Gaspardini G; Saba F; Cherchi V; Mantovani G
    Oral Oncol; 2010 Nov; 46(11):818-21. PubMed ID: 20920877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy for head and neck cancer. Comparison of cisplatin + vinblastine + bleomycin versus methotrexate.
    Williams SD; Velez-Garcia E; Essessee I; Ratkin G; Birch R; Einhorn LH
    Cancer; 1986 Jan; 57(1):18-23. PubMed ID: 2416423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.
    Recloux P; Dodion PF; Andry G; Chantrain G; Dor P; Buyse M; Van Houtte P; Lemort M; Haesendonck P; Larsimont D
    Eur J Surg Oncol; 1989 Dec; 15(6):568-74. PubMed ID: 2480922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Docetaxel and vinorelbine in recurrent head and neck cancer: pharmacokinetic and clinical results.
    Airoldi M; Cattel L; Marchionatti S; Recalenda V; Pedani F; Tagini V; Bumma C; Beatrice F; Succo G; Maria Gabriele A
    Am J Clin Oncol; 2003 Aug; 26(4):378-81. PubMed ID: 12902890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck.
    Herbst RS; Arquette M; Shin DM; Dicke K; Vokes EE; Azarnia N; Hong WK; Kies MS
    J Clin Oncol; 2005 Aug; 23(24):5578-87. PubMed ID: 16009949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoadjuvant carboplatin and vinorelbine followed by chemoradiotherapy in locally advanced head and neck or oesophageal squamous cell carcinoma: a phase II study in elderly patients or patients with poor performance status.
    Koussis H; Scola A; Bergamo F; Tonello S; Basso U; Karahontzitis P; Chiarion-Sileni V; Pasetto L; Ruol A; Loreggian L; Lora O; Bottin R; Marioni G; Donach M; Jirillo A
    Anticancer Res; 2008; 28(2B):1383-8. PubMed ID: 18505084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Espinosa E; Zamora P; Millá A; Morales S; Molina R; Mira M; González Barón M;
    Head Neck; 2002 Dec; 24(12):1054-9. PubMed ID: 12454943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results of primary chemotherapy in 44 patients with advanced squamous cell carcinoma in the area of the head and neck].
    von Heyden HW; Schröder M; Scherpe A; Stennert E; Beyer JH; Nagel GA; Hoffmann H; Schneider B
    HNO; 1984 Nov; 32(11):454-9. PubMed ID: 6210278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous intravenous infusion combination chemotherapy for head and neck squamous cell carcinoma.
    Gonzalez MF; Valdivieso JG; Sartiano GP
    Oncology; 1984; 41(6):377-82. PubMed ID: 6209601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [2d interim evaluation of a chemotherapy study on patients with squamous cell carcinomas of the head-neck area. A comparison of 2 therapy regimens: cis-diamminedichloroplatinum (II) and bleomycin versus methotrexate and vindesine].
    Schröder M; von Heyden HW; Scherpe A; Borghardt J; Beyer JH; Nagel GA; Gerhartz H; Kastenbauer E; Westerhausen M; Schroeder M; Caliebe W; Rudert H; Lissers R; Hofmann J; Schneider B
    Onkologie; 1983 Jun; 6(3):114-7. PubMed ID: 6193472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: a randomised phase II study.
    Fonseca E; Grau JJ; Sastre J; García-Gómez JM; Rueda A; Pastor M; Lara MA; Navalón M; Berrocal A; Tisaire JL; Cruz JJ
    Eur J Cancer; 2005 Jun; 41(9):1254-60. PubMed ID: 15908196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.
    Athanasiadis I; Taylor S; Vokes EE; Pelzer HJ; Rademaker A; Mittal BB; Ganzenko N; Blough R; Lester EP; Kies MS
    Cancer; 1997 Feb; 79(3):588-94. PubMed ID: 9028372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination chemotherapy with vincristine, bleomycin, and methotrexate for advanced head and neck cancers.
    Woods RL; Stewart J; Fox RM; Tattersall MH
    Cancer Treat Rep; 1979; 63(11-12):1997-9. PubMed ID: 93514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
    Wagenaar HC; Colombo N; Vergote I; Hoctin-Boes G; Zanetta G; Pecorelli S; Lacave AJ; van Hoesel Q; Cervantes A; Bolis G; Namer M; Lhommé C; Guastalla JP; Nooij MA; Poveda A; Scotto di Palumbo V; Vermorken JB
    Gynecol Oncol; 2001 Jun; 81(3):348-54. PubMed ID: 11371121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].
    Nishio M; Kagami Y; Narimatsu N; Asano K; Sanbe S; Somekawa Y
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3111-8. PubMed ID: 2476971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant chemotherapy in multiple synchronous head and neck and esophagus squamous cell carcinomas.
    Guillot T; Spielmann M; Kac J; Luboinski B; Tellez-Bernal E; Munck JN; Bachouchi M; Armand JP; Cvitkovic E
    Laryngoscope; 1992 Mar; 102(3):311-9. PubMed ID: 1372059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of escalating doses of paclitaxel plus cisplatin in patients with inoperable head and neck cancer.
    Hitt R; Hornedo J; Colomer R; Hidalgo M; Brandariz A; Peña M; Vicent JA; Cortés-Funes H
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-58-S2-64. PubMed ID: 9045339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.